With the completion of the Human Genome Project and advances in next-generation sequencing, numerous studies have identified significant associations between GCKR variants and metabolic diseases, including type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), and familial hypertriglyceridemia [11,12,13]. The gene discussed is GCKR; the disease is type 2 diabetes mellitus.